Related Experiment Video
Updated: Aug 16, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Diagnosis and management of red cell aplasia in children
1Department of Pediatrics, Stanford University School of Medicine, California.
Insights
Pediatric red blood cell aplasia (RBC aplasia) encompasses various conditions, including Diamond-Blackfan anemia and transient erythroblastopenia of childhood. Further research is needed to clarify the pathophysiology and long-term outcomes of these anemias.
Area of Science:
- Pediatric Hematology
- Oncology
- Immunology
Background:
- Pediatric red blood cell (RBC) hypoplastic anemias are primarily attributed to chronic hemolysis, Diamond-Blackfan anemia (DBA), and transient erythroblastopenia of childhood (TEC).
- Other causes, mirroring adult RBC aplasia, include thymoma, anticonvulsant therapy, malnutrition, hepatitis, and leukemia treatment.
- Many pediatric RBC aplasia cases lack a clear diagnosis, often considered variants of DBA, highlighting diagnostic challenges.
Purpose of the Study:
- To address critical unanswered questions regarding the etiology, pathophysiology, and clinical course of pediatric RBC hypoplastic anemias.
- To investigate the potential link between viral infections and RBC hypoplastic crises.
- To differentiate between laboratory limitations and distinct disease entities within pediatric RBC aplasia.
Main Methods:
- Review of existing literature and case reports on pediatric RBC aplasia.
- Clinical observation of pediatric patients with various forms of RBC aplasia.
- Analysis of diagnostic criteria and potential etiological factors.
Main Results:
- The study highlights the heterogeneity of pediatric RBC aplasia, with common causes like DBA and TEC, and rarer associations with thymoma and specific therapies.
- A case of a 16-year-old with pure RBC aplasia experiencing spontaneous remission is presented, raising questions about adolescent equivalents of TEC.
- Significant diagnostic and etiological questions remain, particularly concerning the cellular pathophysiology of DBA and TEC and the potential for acute leukemia as a complication of DBA.
Conclusions:
- Further research is essential to resolve key questions surrounding pediatric RBC hypoplastic anemias, including their pathophysiology, diagnostic criteria, and long-term prognosis.
- The increasing incidence of TEC warrants further investigation into its causes and potential long-term implications.
- Clarifying the distinct entities within pediatric RBC aplasia is crucial for accurate diagnosis and effective management.
Abstract:
The vast majority of pediatric RBC hypoplastic anemias are accounted for by red blood cell aplasia associated with chronic hemolysis, Diamond-Blackfan anemia, and transient erythroblastopenia of childhood. However, other causes of hypoplastic anemia occur in children, and some of these are similar to what is seen in adult RBC aplasia. For example, it has been reported that a 5-year-old girl with an aregenerative anemia had a thymoma and later developed pancytopenia. RBC aplasia also has been seen in children receiving anticonvulsant drug therapy, children recovering from severe protein malnutrition, children with hepatitis, and in children with leukemia during maintenance therapy. In addition, it is not uncommon for pediatric hematologists to observe children with RBC aplasia where there is no obvious diagnosis, although many are considered to be variants of Diamond-Blackfan anemia. Several important questions about RBC hypoplastic anemias in children need to be resolved; it is hoped that this will be accomplished in the next decade. Do RBC hypoplastic crises associated with hemolytic anemia occur with viral infections other than HPV? What is the cellular pathophysiology in DBA and TEC? Does the apparent heterogeneity of these disorders reflect limitations of laboratory techniques or are we looking at several different diseases? Is acute leukemia a real complication of Diamond-Blackfan anemia? Is TEC a completely benign entity or will we see other long-term problems in these children? Is the incidence of TEC actually increasing? Will TEC-like problems be seen in other aged children? As a case in point, we recently observed a 16-year-old girl who presented with pure RBC aplasia that required RBC transfusion support for 5 months; she also received prednisone therapy. After 7 months, however, this young lady had a spontaneous remission, and now 4 years later she is normal and free of any hematologic abnormalities. This was a most unusual event in our experience and, in view of the apparent increasing incidence of TEC in young children, we queried whether we were observing an adolescent equivalent of this disorder. During the next several years the answer to this and the other questions posed herein should be available.
More Related Videos
Related Concept Videos
Erythropoiesis
Regulation of Hematopoietic Stem Cells
Overview of Hematopoiesis
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Rh Blood Group
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

